| pubmed-article:17204683 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C0032143 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C0019080 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C0751956 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C1510411 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C0022116 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C0439793 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C0333275 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C1292428 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C0520997 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C0445223 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C1552599 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C1704787 | lld:lifeskim |
| pubmed-article:17204683 | lifeskim:mentions | umls-concept:C2926735 | lld:lifeskim |
| pubmed-article:17204683 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17204683 | pubmed:dateCreated | 2007-1-30 | lld:pubmed |
| pubmed-article:17204683 | pubmed:abstractText | Intracerebral hemorrhage represents the most feared complication of treatment with intravenous tissue plasminogen activator. We studied whether perfusion-weighted imaging and diffusion-weighted imaging has the potential to identify patients at risk of severe intracerebral hemorrhage after treatment with intravenous tissue plasminogen activator. | lld:pubmed |
| pubmed-article:17204683 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17204683 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17204683 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17204683 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17204683 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17204683 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:17204683 | pubmed:issn | 1524-4628 | lld:pubmed |
| pubmed-article:17204683 | pubmed:author | pubmed-author:RötherJoachim... | lld:pubmed |
| pubmed-article:17204683 | pubmed:author | pubmed-author:FiehlerJensJ | lld:pubmed |
| pubmed-article:17204683 | pubmed:author | pubmed-author:KucinskiThoma... | lld:pubmed |
| pubmed-article:17204683 | pubmed:author | pubmed-author:KöhrmannMarti... | lld:pubmed |
| pubmed-article:17204683 | pubmed:author | pubmed-author:ThomallaGötzG | lld:pubmed |
| pubmed-article:17204683 | pubmed:author | pubmed-author:SobeskyJanJ | lld:pubmed |
| pubmed-article:17204683 | pubmed:author | pubmed-author:SchellingerPe... | lld:pubmed |
| pubmed-article:17204683 | pubmed:author | pubmed-author:FiebachJochen... | lld:pubmed |
| pubmed-article:17204683 | pubmed:author | pubmed-author:RosenkranzMic... | lld:pubmed |
| pubmed-article:17204683 | pubmed:author | pubmed-author:Zaro... | lld:pubmed |
| pubmed-article:17204683 | pubmed:author | pubmed-author:KruetzelmannA... | lld:pubmed |
| pubmed-article:17204683 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17204683 | pubmed:volume | 38 | lld:pubmed |
| pubmed-article:17204683 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17204683 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17204683 | pubmed:pagination | 313-8 | lld:pubmed |
| pubmed-article:17204683 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:meshHeading | pubmed-meshheading:17204683... | lld:pubmed |
| pubmed-article:17204683 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17204683 | pubmed:articleTitle | Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. | lld:pubmed |
| pubmed-article:17204683 | pubmed:affiliation | Neuro-Zentrum, Klinik und Poliklinik für Neurologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. thomalla@uke.uni-hamburg.de | lld:pubmed |
| pubmed-article:17204683 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17204683 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:17204683 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17204683 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17204683 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17204683 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17204683 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17204683 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17204683 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17204683 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17204683 | lld:pubmed |
